LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 199 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,955,023 | -18.4% | 282,961 | -1.8% | 1.08% | -8.7% |
| Q2 2023 | $20,776,248 | -2.0% | 288,159 | -0.1% | 1.18% | -2.2% |
| Q1 2023 | $21,210,681 | +11.2% | 288,345 | +0.9% | 1.20% | +10.1% |
| Q4 2022 | $19,080,351 | -25.3% | 285,634 | -3.7% | 1.09% | -26.1% |
| Q3 2022 | $25,547,000 | -14.4% | 296,678 | -11.3% | 1.48% | +2.6% |
| Q2 2022 | $29,857,000 | -23.1% | 334,642 | -3.0% | 1.44% | -6.7% |
| Q1 2022 | $38,806,000 | -27.7% | 344,969 | -0.8% | 1.55% | -18.9% |
| Q4 2021 | $53,706,000 | +3.1% | 347,699 | -7.0% | 1.91% | -0.9% |
| Q3 2021 | $52,067,000 | +4.8% | 373,720 | -1.3% | 1.92% | +8.9% |
| Q2 2021 | $49,685,000 | -24.2% | 378,726 | -11.9% | 1.77% | -17.3% |
| Q1 2021 | $65,562,000 | +30.8% | 430,056 | -14.7% | 2.14% | +21.1% |
| Q4 2020 | $50,139,000 | +36.1% | 504,159 | +30.4% | 1.76% | +18.8% |
| Q3 2020 | $36,842,000 | -0.7% | 386,506 | +16.5% | 1.48% | -6.8% |
| Q2 2020 | $37,105,000 | +50.8% | 331,740 | -2.0% | 1.59% | +15.9% |
| Q1 2020 | $24,607,000 | -22.0% | 338,376 | +11.9% | 1.38% | +28.9% |
| Q4 2019 | $31,548,000 | +0.4% | 302,503 | -4.2% | 1.07% | -5.1% |
| Q3 2019 | $31,430,000 | -14.6% | 315,754 | -2.0% | 1.12% | -8.0% |
| Q2 2019 | $36,784,000 | -14.5% | 322,245 | -5.8% | 1.22% | -11.8% |
| Q1 2019 | $43,011,000 | +15.3% | 342,141 | +24.5% | 1.38% | +1.8% |
| Q4 2018 | $37,306,000 | -29.0% | 274,917 | +43.7% | 1.36% | -27.6% |
| Q3 2018 | $52,518,000 | -5.0% | 191,331 | -28.3% | 1.88% | -6.5% |
| Q2 2018 | $55,298,000 | +9.9% | 266,920 | -12.4% | 2.01% | +2.4% |
| Q1 2018 | $50,323,000 | +19.8% | 304,692 | -0.7% | 1.96% | +19.0% |
| Q4 2017 | $42,018,000 | +15.1% | 306,858 | +14.5% | 1.65% | +2.2% |
| Q3 2017 | $36,490,000 | +7.6% | 268,014 | -4.1% | 1.62% | +9.5% |
| Q2 2017 | $33,917,000 | +46.0% | 279,382 | +27.3% | 1.48% | +30.3% |
| Q1 2017 | $23,232,000 | +8.6% | 219,500 | +4.2% | 1.13% | +4.9% |
| Q4 2016 | $21,397,000 | +0.4% | 210,575 | +0.8% | 1.08% | -3.1% |
| Q3 2016 | $21,316,000 | -3.8% | 208,859 | +12.4% | 1.11% | -12.8% |
| Q2 2016 | $22,164,000 | +12.3% | 185,829 | +0.8% | 1.28% | +12.0% |
| Q1 2016 | $19,744,000 | +0.9% | 184,371 | +2.2% | 1.14% | +2.0% |
| Q4 2015 | $19,560,000 | +120.7% | 180,412 | +74.3% | 1.12% | +94.8% |
| Q3 2015 | $8,864,000 | -7.5% | 103,488 | +9.0% | 0.57% | +3.8% |
| Q2 2015 | $9,582,000 | +19.0% | 94,965 | -9.0% | 0.55% | +18.7% |
| Q1 2015 | $8,050,000 | – | 104,393 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |